Strs Ohio Has $12.31 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Strs Ohio raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 14.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 159,174 shares of the company’s stock after buying an additional 20,333 shares during the quarter. Strs Ohio’s holdings in GE HealthCare Technologies were worth $12,307,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Armstrong Henry H Associates Inc. boosted its stake in shares of GE HealthCare Technologies by 3.9% in the 3rd quarter. Armstrong Henry H Associates Inc. now owns 4,105 shares of the company’s stock valued at $279,000 after purchasing an additional 153 shares in the last quarter. Chicago Capital LLC boosted its position in GE HealthCare Technologies by 2.8% in the third quarter. Chicago Capital LLC now owns 6,081 shares of the company’s stock valued at $414,000 after buying an additional 163 shares in the last quarter. Chilton Capital Management LLC boosted its position in GE HealthCare Technologies by 15.4% in the fourth quarter. Chilton Capital Management LLC now owns 1,227 shares of the company’s stock valued at $95,000 after buying an additional 164 shares in the last quarter. Procyon Advisors LLC grew its stake in shares of GE HealthCare Technologies by 5.2% during the fourth quarter. Procyon Advisors LLC now owns 3,555 shares of the company’s stock worth $275,000 after buying an additional 175 shares during the last quarter. Finally, Meeder Advisory Services Inc. increased its holdings in shares of GE HealthCare Technologies by 5.4% during the fourth quarter. Meeder Advisory Services Inc. now owns 3,634 shares of the company’s stock worth $281,000 after buying an additional 185 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 0.8 %

NASDAQ:GEHC opened at $85.19 on Thursday. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The firm’s fifty day moving average is $88.61 and its 200-day moving average is $77.65. The firm has a market cap of $38.87 billion, a P/E ratio of 28.21, a P/E/G ratio of 3.00 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. The business had revenue of $5.20 billion during the quarter, compared to the consensus estimate of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.31 earnings per share. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.97%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the company. HSBC started coverage on GE HealthCare Technologies in a research report on Thursday, February 15th. They set a “buy” rating and a $100.00 price objective on the stock. Argus boosted their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a report on Monday, April 1st. Mizuho raised their price objective on shares of GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a report on Thursday, April 11th. Citigroup lifted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Finally, Evercore ISI upped their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies presently has an average rating of “Moderate Buy” and an average price target of $95.08.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.